Log In
Print
BCIQ
Print
Print this Print this
 

Resokine

  Manage Alerts
Collapse Summary General Information
Company aTyr Pharma Inc.
DescriptionProtein therapy based on non-canonical functions of secreted forms of aminoacyl tRNA synthetases
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat rare diseases related to the immune system
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today